|
SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY
An affiliate of The American society for Reproductive Medicine
June 17, 1998
To: SART Practice Directors
From: SART Executive Council
Re: Advertising
The American Society for Reproductive Medicine issued "Guidelines
for Advertising by ART Programs" in January 1998. Subsequent to
that , the SART Executive Council issued a memo to all its members (April
1-7, 1998) outlining how it would handle misleading or inaccurate advertising.
Despite these advisories.. we continue to receive copies of advertisements
that are clearly in violation of the guidelines.
The purpose of the Clinic Specific Report is to provide information
as a service to the public in. compliance with the Fertility Clinic
Success Rate and Certification Act of 1992. It was never intended to
be used to rank practices or to allow for direct comparisons between
practices. The variables in patient selection, treatment processes,
as well as program policies influence the statistics and make comparisons
unreliable. Unfortunately, the Clinic Specific Report continues to be
misused for marketing purposes. As a result. the SART Executive Council
has approved the following policy effective July 1, 1998:
Because comparison of success rates between practices is invalid, using
SART Clinic Specific Data for advertising/marketing that ranks or compares
clinics or practices is unacceptable and is not permitted. Violation
of this policy constitutes grounds to deny continued membership in SART.
The SART Practice Committee will review all advertising brought to its
attention. Infractions will be referred to the SART Executive Council.
The practice in violation will be served notice that it must provide
proof of a public retraction in a similar format to the statement(s)
in question or otherwise resolve the complaint to the satisfaction of
the Executive Council within a specified
time me frame.
The name of the practice in violation of the advertising policy will
then be referred to the Oversight Committee which in turn will notify
the CDC. FTC, FDA and RESOLVE. The names of these practices will also
be published in SARTimes ASRM News, and on the SART website.
Any practice notified of pending loss of SART membership will have ten
days s to write a letter to appeal to the SART Executive Council. The
SART Executive Council will then review the situation and make a final
decision within thirty days. Loss of SART membership due to 'violation
of advertising policy will preclude reapplication for SART membership
for a period of not less than one year.
If you have any questions, you may call us at (314) 576-1400.
|